Recursion Pharmaceuticals Inc (RXRX)

Recursion Pharmaceuticals Inc (RXRX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	141.88%18.55	7.67	6.47	35.54	5.18
Cost Of Revenue	12.58%10.05	11.49	12.49	14.28	14.69
	10.61%99.12	89.61	87.90	-	-
Research and Development	10.61%99.12	89.61	87.90	-	-
Costs And Expenses	0.64%141.73	142.64	134.98	143.87	177.38
Operating Income/Loss	8.74%-123.18	-134.97	-128.51	-108.33	-172.20
Nonoperating Income/Loss	5.12%4.17	3.96	6.40	0.23	9.95
Income/Loss From Continuing Operations Before Tax	9.16%-119.01	-131.01	-122.11	-108.10	-162.25
Income Tax Expense/Benefit, Deferred	100.00%-	-0.00	-4.60	-	-
Income Tax Expense/Benefit	2,600%0.03	-0.00	-4.60	0.02	0.00
	9.14%-119.04	-131.01	-117.50	-108.12	-162.25
Attributable To Parent	9.14%-119.04	-131.01	-117.50	-108.12	-162.25
Basic Average Shares	1.98%543.00	532.46	529.30	24.80	446.99
Diluted Average Shares	1.98%543.00	532.46	529.30	24.80	446.99
Basic Earnings Per Share	12.00%-0.22	-0.25	-0.22	-0.17	-0.36
Diluted Earnings Per Share	12.00%-0.22	-0.25	-0.22	-0.17	-0.36